NYSE : DHR
Danaher Corporation — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 236.98 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 166.72B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 163.38B |
| Enterprise Value | 185.48B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | Sep 30, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 703.53M |
| Shares Outstanding | 703.53M |
| Shares Change (YoY) | -1.60% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 10.86% |
| Owned by Institutions (%) | 82.93% |
| Float | 626.34M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 38.05 |
| Forward PE | 25.54 |
| PS Ratio | 6.38 |
| Forward PS | 5.85 |
| PB Ratio | 3.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 28.53 |
| P/OCF Ratio | 23.82 |
| PEG Ratio | 2.87 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 42.83 |
| EV / Sales | 7.24 |
| EV / EBITDA | 22.47 |
| EV / EBIT | 32.97 |
| EV / FCF | 32.39 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.63 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 3.24 |
| Debt / FCF | 4.85 |
| Interest Coverage | 15.63 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 8.19% |
| Return on Assets (ROA) | 4.06% |
| Return on Invested Capital (ROIC) | 6.60% |
| Return on Capital Employed (ROCE) | 6.68% |
| Weighted Average Cost of Capital (WACC) | 7.55% |
| Revenue Per Employee | $426,800 |
| Profits Per Employee | $72,183 |
| Employee Count | 60,000 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 3.58 |
Taxes
| Measure | Value |
|---|
| Income Tax | 529.00M |
| Effective Tax Rate | 10.98% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +8.51% |
| 50-Day Moving Average | 218.85 |
| 200-Day Moving Average | 201.11 |
| Relative Strength Index (RSI) | 58.12 |
| Average Volume (20 Days) | 4,453,050 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 8.14M |
| Short Previous Month | 8.34M |
| Short % of Shares Out | 1.16% |
| Short % of Float | 1.30% |
| Short Ratio (days to cover) | 1.76 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 25.61B |
| Gross Profit | 15.20B |
| Operating Income | 5.63B |
| Pretax Income | 4.82B |
| Net Income | 4.33B |
| EBITDA | 8.26B |
| EBIT | 5.63B |
| Earnings Per Share (EPS) | $6.10 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 5.68B |
| Total Debt | 27.78B |
| Net Cash | -22.10B |
| Net Cash Per Share | -$31.41 |
| Equity (Book Value) | 53.63B |
| Book Value Per Share | 76.23 |
| Working Capital | 5.74B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 6.86B |
| Capital Expenditures | -1.13B |
| Depreciation & Amortization | 2.63B |
| Net Borrowing | 10.31B |
| Free Cash Flow | 5.73B |
| FCF Per Share | $8.14 |
Margins
| Measure | Value |
|---|
| Gross Margin | 59.36% |
| Operating Margin | 21.97% |
| Pretax Margin | 18.81% |
| Profit Margin | 16.91% |
| EBITDA Margin | 32.24% |
| EBIT Margin | 21.97% |
| FCF Margin | 22.36% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $1.60 |
| Dividend Yield | 0.69% |
| Dividend Growth (YoY) | 23.58% |
| Years of Dividend Growth | 8 |
| Payout Ratio | 24.90% |
| FCF Payout Ratio | 18.67% |
| Buyback Yield | 1.60% |
| Shareholder Yield | 2.29% |
| Earnings Yield | 2.63% |
| FCF Yield | 3.51% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $259.90 |
| Price Target Difference | 11.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | 7.10% |
| EPS Growth Forecast (3Y) | 9.66% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 14, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.47 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |